Kotak Institutional Equities suggests that high US tariffs on pharmaceuticals are unlikely. They maintain an optimistic ...

Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized ...

The Nifty Pharma index closed on a negative note on Thursday. Shares of Sun Pharmaceutical Industries Ltd.(up 2.11 per cent), ...

Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...

Guidance for Total Revenues, Adjusted EBITDA and Adjusted EPS; Exceeds 2024 Guidance for Free Cash Flow [1] Reports 2024 ...

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it ...

AM(IST)on Thursday in an upbeat market. Gland Pharma Ltd.(up 2.48 per cent), Lupin Ltd.(up 0.53 per cent), Alkem Laboratories ...

India's AVGC-R sector at its peak, merging technology and creativity to showcase rich cultural heritage globally.

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical ...

SBI Card price is retesting its breakout from a consolidation zone with a surge in buying volumes visible on the daily scale.